We will be participating today at the AI Applications for Big Data in (Bio)Pharma. Our Sr Dir of Strategic Partnerships will be covering the topic of Data Contracting & Ownership Models at 12:35-1:05p ET.
Make sure to tune in!
#RNA#BigData
We will be participating in the upcoming AI Applications for Big Data in (Bio)Pharma taking place 5/19. Our Sr Dir of Strategic Partnerships will be covering the topic of Data Contracting & Ownership Models at 12:35-1:05p ET.
To register: bit.ly/3LeSJH3#RNA#BigData
Today is the Day Two of the 33rd Annual Cancer Progress Conference!
Make sure to listen in to the panel Does RNA Rule the World (2:30-3:30p ET) where Envisagenics' Co-founder & CEO will be participating.
More info: cancerprogress.live/#RNA#DrugDiscovery
Thank you to those who came by Envisagenics' poster session yesterday @AACR hosted by Alyssa Casill (@alyssacasill)! Great turnout discussing how Envisagenics' SpliceCore platform discovered novel RNA therapeutics for #breastcancer using AI/ML.
#RNA#Splicing#DrugDiscovery
It’s not often that we get to meet with our team members in-person, but we’re very glad that we were able to do so!
Here’s to Envisagenics’ team outing and the fantastic work we are doing in the AI/ML and RNA splicing sector of the industry. Cheers!
Excited to be participating at the American Association for Cancer Research in New Orleans, LA (April 8-13).
Our poster will be in Section 26 (Exhibit Halls D-H). Make sure to add to your agenda!
For more info: abstractsonline.com/pp8/#!/1…#RNA#Splicing#DrugDiscovery#AACR
Envisagenics' Co-founder & CTO, @makerman30, will be participating in a panel at @OGConferences Biologics UK with MiNA Therapeutics, Stoke Therapeutics, Regulus Therapeutics, and GSK.
Starts at 2:30pm GMT. Make sure to listen in!
#RNA#Splicing#DrugDiscovery
For those in #SXSW, hope you are all enjoying the event!
Envisagenics will be participating in a panel starting at 10:00am through 11:00am CT - make sure to listen in if you are interested in a The $5T Opportunity: Gender Parity in Tech.
It is day two of @SMipharm's AI in Drug Discovery event!
The Use of AI in Drug Discovery for the Treatment of Rare Diseases will be starting at 14:40 GMT.
Make sure to listen in!
#RNA#ArtificialIntelligence#Splicing#DrugDiscovery
Envisagenics' Co-founder & CEO will be attending @SMipharm AI in Drug Discovery. Maria will be participating in a panel at 14:40GMT (The Use of AI in Drug Discovery for the Treatment of Rare Diseases).
Make sure to stop by our session!
#DrugDiscovery#ArtificialIntelligence
Envisagenics' Co-founder & CEO, Maria Luisa Pineda, PhD., will be participating at #SXSW alongside Priyanka Mitra (@M12vc), Michelle Zhu (@huuebio), and Cecilia Flores (@WebeeLife) to discuss gender parity across the industries. Panel will take place on March 15 10:00-11:00a CT.
Thank you to everyone who participated in the painting class! It was a joy to come together to share our creative spirits. The Envisagenics' team is gifted in so many ways. We look forward to the next happy hour event!
#RNA#Splicing#DrugDiscovery
International Day of Women & Girls in Science is a reminder for us that women and girls are essential to the opportunity and innovation in #STEM. As a women-led #biotech, today is like any other Friday – we tirelessly champion access to science for all women out there.
The Moderna COVID-19 vaccine development is in large part thanks to a Black woman named Dr. Kizzmekia "Kizzy" Corbett. Just 34 years old when the pandemic began, the NIH immunologist co-led the team that worked with Moderna to develop the vaccine. Follow Dr. Corbett @KizzyPhD
Dr. Rebecca Lee Crumpler was the first Black woman to earn an MD in the US, as well as one of the first Black medical authors in the country. As a doctor, she was devoted to “caring for freed slaves who would otherwise have had no access to medical care.” bit.ly/3LpzVGH
Envisagenics' CTO/Co-founder and VP of Biology will be participating at @SMipharm 13th Annual RNA Therapeutics conference on February 9-10.
Our presentation and panels are taking place on Day Two. Make sure to listen in!
#RNA#Splicing#DrugDiscovery
For #BlackHistoryMonth, we are spotlighting Katherine Johnson who broke barriers as a mathematician.
“Some things will drop out of the public eye and will go away, but there will always be science, engineering, and technology. And there will always, always be mathematics.” - KJ
Envisagenics' CTO/Co-founder and VP of Biology will be virtually participating at @SMipharm 13th Annual RNA Therapeutics conference on February 9-10.
For more information and registration: lnkd.in/dikwJExt#RNA#Splicing#DrugDiscovery